BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, March 29, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
July 13, 2001
View Archived Issues
Primary endpoint achieved in phase III trial of Gilead's adefovir dipivoxil for HBV
Read More
Use of PRAC protein in cancer Rx available for licensing from NIH
Read More
Licensing opportunity from NIH: new small RNAs as starting point for antibiotic development
Read More
Medicure presents drug with potential for healing ischemic injury
Read More
Protein Therapeutics begins phase II trial in juvenile RA
Read More
Medivir highlights pipeline progress for first half of 2001
Read More
Design of mixed direct thrombin and factor Xa inhibitors reported at ISTH
Read More
Antiplatelet antibody fragment designed at Chinese university
Read More
HTU-PA is a safe and effective thrombolytic agent in acute myocardial infarction
Read More
Beneficial effects of humanized anti-hTF antibody in hypercoagulable states
Read More
Safer anticoagulation obtained with Ro-67-8698, a new factor VIIa inhibitor, than napsagatran
Read More
MabCampath approved in Europe for B-CLL
Read More
Lilly Icos seeks European approval of Cialis for treatment of erectile dysfunction
Read More
Sea cucumber-based therapy useful for age-associated dementia
Read More
EMEA accepts Oxford GlycoSciences' MAA for Vevesca
Read More
Cangene halts pilot phase II trial of anti-HCV hyperimmune product
Read More
Protective effect demonstrated for FR-167653 against aspirin-induced gastric damage
Read More
FTY-720: effects on lymphocytes and in animal models of autoimmune diseases
Read More
Ramoplanin granted orphan drug status in Europe
Read More
EntreMed begins enrollment of initial patients in phase I/II study of rhEndostatin
Read More
Antithrombotic pentasaccharide covered extensively at recent scientific meeting
Read More
Inhibitors of PDE4 and use in asthma, allergies, etc.
Read More
Merck & Co. presents new pyrazinone thrombin inhibitors
Read More
Agents for HBV and HIV described in patent literature by Korean lab
Read More
Tie2 receptor kinase inhibitors useful for angiogenic disorders
Read More
Urotensin II analogues and pharmaceutical compositions for stroke and other disorders
Read More
Venlafaxine metabolite ethers with same pharmacological profile as venlafaxine
Read More